TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/2/24 16:59 | 5/1/24 | FENC | Fennec Pharmaceuticals Inc. | A1 | Health | BioPrd | Biological Products, (No Diag | Raykov Rosty | NC | DO | CEO | S | -22 | 9.11 | 0 | -2 | -1 | 187 | D | ||||||||||||||
4/5/24 16:56 | 4/4/24 | FENC | Fennec Pharmaceuticals Inc. | A1 | Health | BioPrd | Biological Products, (No Diag | Raykov Rosty | NC | DO | CEO | S.m | -959 | 10.82 | 0 | -89 | -32 | 187 | D | ||||||||||||||
4/3/24 17:37 | 4/3/24 | FENC | Fennec Pharmaceuticals Inc. | A1 | Health | BioPrd | Biological Products, (No Diag | Raykov Rosty | NC | DO | CEO | S | -437 | 10.78 | 0 | -41 | -13 | 276 | D | ||||||||||||||
12/29/23 16:30 | 12/28/23 | FENC | Fennec Pharmaceuticals Inc. | A1 | Health | BioPrd | Biological Products, (No Diag | Raykov Rosty | NC | DO | CEO | S.d | -42 | 11.55 | 0 | -4 | -1 | 287 | D | ||||||||||||||
11/9/23 16:38 | 11/8/23 | FENC | Fennec Pharmaceuticals Inc. | A1 | Health | BioPrd | Biological Products, (No Diag | Raykov Rosty | NC | DO | CEO | S | -194 | 7.76 | 0 | -25 | -8 | 283 | D | ||||||||||||||
12/30/22 17:09 | 12/28/22 | FENC | Fennec Pharmaceuticals Inc. | A1 | Health | BioPrd | Biological Products, (No Diag | Raykov Rosty | NC | DO | CEO | S.m | -276 | 9.61 | 0 | -29 | -12 | 218 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |